Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply

Lamarca, A, Palmer, DH, Wasan, HS et al. (18 more authors) (2021) Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply. The Lancet Oncology, 22 (7). e288-e289. ISSN 1470-2045

Metadata

Authors/Creators:
  • Lamarca, A
  • Palmer, DH
  • Wasan, HS
  • Ross, PJ
  • Ma, YT
  • Arora, A
  • Falk, S
  • Gillmore, R
  • Wadsley, J
  • Patel, K
  • Anthoney, A
  • Maraveyas, A
  • Iveson, T
  • Waters, JS
  • Hobbs, C
  • Barber, S
  • Ryder, WD
  • Ramage, J
  • Davies, LM
  • Bridgewater, JA
  • Valle, JW
Dates:
  • Published: July 2021
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 27 Oct 2021 13:04
Last Modified: 27 Oct 2021 13:04
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/s1470-2045(21)00341-7
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)